Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II
Introduction
Endocrine disrupting chemicals (EDCs) are exogenous chemicals, or mixture of chemicals, that can interfere with any aspect of hormone action [1]. Many of these substances have been linked with developmental, reproductive, neural, immune, and other problems in wildlife and laboratory animals [2•]. Most environmental chemicals have never been fully assessed for potential endocrine activity, thus information regarding how many EDCs exists in our environment, how humans are exposed, and to what degree they post a risk to human health is limited [2•]. As the largest funding agency for EDC research, the National Institute of Environmental Health Sciences (NIEHS) has tended to focus on a relatively small number of chemicals such as bisphenols, phthalates, halogenated persistent compounds, genistein and other isoflavones, and certain pesticides (Figure 1). This focus on a relatively few chemicals is partly due to a lack of research tools to help identify and prioritize which chemicals to study based on indications of potential endocrine activity. Moreover, it can be very difficult to obtain funding support to generate descriptive information on data-poor chemicals in the absence of a specific hypothesis to test. Because chemicals can enter the marketplace (with some exceptions) without any toxicity information, researchers typically have nothing to go on to develop hypotheses.
High throughput screening approaches within the toxicological community hope to help identify chemicals with potential endocrine activity. The USEPA ToxCast program has completed Phase II screening efforts of 1858 unique chemicals in hundreds of HTS assays [3•] (Figure 2). Screening programs like ToxCast are a major component of modern toxicology, necessitated by the recognition that animal studies alone are insufficient to generate data on thousands of chemicals in terms of cost, time, and throughput, Previously, Reif et al. [4••] developed a Toxicological Priority Index (ToxPi) model to describe and prioritize 309 unique chemicals for potential endocrine activity using Phase I ToxCast data. ToxPi is an information graphic used to display information on a chemical's bioactivity profiles, inferred toxicity pathways, dose estimates, exposure data, chemical structural descriptors, or other features [5]. The purpose of this article is twofold. First, we use state of the art approaches for analyzing HTS data to identify environmental chemicals with potential endocrine activity. We did this by updating the previous prioritization scheme with Phase II ToxCast data, covering an additional 1549 chemicals. In addition to expanding the chemical coverage, we also made minor changes to the model methodology and included several other EDC assay targets of growing interest in environmental health. The updated prioritization scheme focuses on the classic targets of the estrogen, androgen, and thyroid pathways as well as targets of emerging interest such as the glucocorticoid receptor, peroxisome proliferator-activated receptors (PPARs), and monoamine signaling. Second, through this exercise, we review the strengths and weaknesses of the ToxPi tool, and identify potential new endocrine disruptors which might be an important focus of future research efforts. Thus, this review both summarizes and enhances ToxPi-based screens of ToxCast chemicals for endocrine disrupting chemicals and advocates for engagement and further work on strengthening screening and prioritization strategies.
Section snippets
Publicly available ToxCast data
ToxCast currently provides results from 821 assay endpoints that make use of numerous technology platforms from seven vendors [3•] (Figure 2). These platforms include both cell-free (biochemical) and cell-based measures in multiple human primary cells, human or rodent cell lines, and rat primary hepatocytes [6]. A wide spectrum of biological targets or effects is covered, including cytotoxicity, cell growth, genotoxicity, enzymatic activity, receptor binding, reporter gene activity (mostly
Updates to ToxPi prioritization scheme
The methodology used in this review builds on previous work by Reif et al. [4••] where 309 chemicals tested in Phase 1 of ToxCast were profiled for potential estrogen, androgen, and thyroid disruption. In this review we expand the original prioritization scheme by summarizing the currently available data for the larger 1858 chemical ToxCast library. In addition to traditional endocrine disruption targets, we highlighted an expanded list of endocrine-related targets to include areas of emerging
Updated EDC ToxPi findings
Figure 3 summarizes one approach for identifying some of the most active environmental compounds. We show the ToxPi profiles for the 30 top scoring chemicals, excluding pharmaceutical and endogenous compounds. The list includes chemicals with specific profiles, like zearalenone and bisphenol AF showing potential estrogenic activity, and chemicals like apigenin with less specific profiles. We also demonstrate an alternative strategy where we identified the top scoring chemicals for each specific
Conclusions
We encourage others to use the public ToxCast data to explore their own hypotheses about specific axes of toxicological hazard probed by this diverse assay set. Here, we have explored one such axis, endocrine activity, by building a ToxPi prioritization scheme from relevant ToxCast assays and placing the results in context with reference chemicals having known EDC activity. Information on the assays can be accessed through the iCSS Dashboards (http://actor.epa.gov/dashboard/), which includes
Author contributions
DF, HP, TS, DR, and KT conceived of the scope of the review and contributed to manuscript preparation. DF conducted the analyses of ToxCast data. TS conducted analyses of NIEHS extramural funding portfolios.
Disclaimer
The views expressed in this article are those of the authors and do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.
References and recommended reading
Papers of particular interest, published within the period of review, have been highlighted as:
• of special interest
•• of outstanding interest
Conflict of interest statement
Nothing declared.
Acknowledgments
We gratefully acknowledge the contributions of Scott Auerbach, Jerry Heindel, Richard Judson, and Rusty Thomas for reviewing draft versions of the manuscript.
References (16)
- et al.
The Matthew effect in environmental science publication: a bibliometric analysis of chemical substances in journal articles
Environ Health
(2011) - et al.
Vom Saal FSCINNRES Pmid: endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society
Endocrinology
(2012) - et al.
Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management
Chem Res Toxicol
(2012) - et al.
Endocrine profiling and prioritization of environmental chemicals using ToxCast data
Environ Health Perspect
(2010) - et al.
GUI: an interactive visualization tool for transparent integration of data from diverse sources of evidence
Bioinformatics
(2013) - et al.
In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project
Environ Health Perspect
(2010) - et al.
Aggregating data for computational toxicology applications: the U.S Environmental Protection Agency (EPA) Aggregated Computational Toxicology Resource (ACToR) System
Int J Mol Sci
(2012)
Cited by (61)
Metabolism disrupting chemicals in the development of human diseases
2023, Environmental Contaminants and Endocrine HealthIdentification of nonmonotonic concentration-responses in Tox21 high-throughput screening estrogen receptor assays
2022, Toxicology and Applied PharmacologyA toxicogenomic data space for system-level understanding and prediction of EDC-induced toxicity
2021, Environment InternationalCitation Excerpt :For this test, the mesh IDs of EDCs and negative controls were translated to CAS ids and the active assay endpoints for each compound were identified from the ToxCast hit call matrix. For the comparison with ToxPi-based scores, we selected compounds, which have been characterized as endocrine disruptors by using the ToxPi scoring system (Filer et al., 2014). The comparative analysis was conducted on chemicals annotated with a CAS number the intersection.
Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid
2021, Advances in PharmacologyToxicity testing and endocrine disrupting chemicals
2021, Advances in PharmacologyCitation Excerpt :The US EPA's Toxicity Forecaster Program (ToxCast) uses high-throughput technology to screen the effects of chemicals on hundreds of outcomes, including many that are relevant to endocrine disruption (Judson et al., 2010). For example, ToxCast assays that are relevant to EDCs include evaluations of estrogen, androgen, thyroid, glucocorticoid, and peroxisome proliferator-activated receptors (Filer, Patisaul, Schug, Reif, & Thayer, 2014). These assays evaluate numerous concentrations of each test chemical, pipetted with robots onto multi-well plates, to build predictive models of chemical hazard.